Who owns Karyopharm Therapeutics Inc note 3.000%10/1?
- CUSIP Number: 48576uaa4
Tip: Access positions for across all investors
Analyze quarterly positions in Karyopharm Therapeutics Inc note 3.000%10/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Karyopharm Therapeutics Inc note 3.000%10/1 stock
Who bought or sold Karyopharm Therapeutics Inc note 3.000%10/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Braidwell | 66M | $36M | 0% | Mar 2024 |
|
| Highbridge Capital Management | 32M | $17B | 0% | Mar 2024 |
|
| Davidson Kempner Capital Management | 29M | $15M | 16% | Mar 2024 |
|
| Capstone Investment Advisors | 7.5M | $4.1M | 0% | Mar 2024 |
|
| Birch Grove Capital | 6.0M | $3.2B | -25% | Mar 2024 |
|
| Lazard Asset Management | 5.5M | $2.8M | -15% | Dec 2023 |
|
| DeepCurrents Investment Group | 5.3M | $4.7M | 0% | Mar 2024 |
|
| Verition Fund Management | 1.7M | $897k | 121607% | Mar 2024 |
|
| BLB^B Advisors | 75k | $40k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 38k | $20k | 0% | Mar 2024 |
|
| Context Capital Management | 22k | $12M | -100% | Mar 2024 |
|